A novel self-assembled nanoparticle platform based on pectin-eight-arm polyethylene glycol-drug conjugates for co-delivery of anticancer drugs

Materials Science and Engineering C

Volumn 86, Issue , 2018, Pages 28-41

  Liu, Yanxue ^a   Liu, Kefeng ^a   Li, Xiaomin ^a   Xiao, Shangzhen ^a   Zheng, Dan ^a   Zhu, Pengbo ^a   Li, Chunxiao ^a   Liu, Jing ^a   He, Jing ^a   Lei, Jiandu ^a   Wang, Luying ^a  

^a BEIJING FORESTRY UNIVERSITY   (China)

Author keywords

Co delivery; Conjugate; Nanoparticle; Pectin; Self assemble

Indexed keywords

CONTROLLED DRUG DELIVERY; CYTOTOXICITY; EFFICIENCY; ENCAPSULATION; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYETHYLENES; SELF ASSEMBLY; TARGETED DRUG DELIVERY;

CO DELIVERIES; CONJUGATE; DRUG CONTROLLED RELEASE; DRUG DELIVERY SYSTEM; ENCAPSULATION EFFICIENCY; PECTIN; SELF ASSEMBLED NANOPARTICLES; SELF-ASSEMBLE;

DRUG DELIVERY;

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG CARRIER; HYDROXYCAMPTOTHECINUM; MACROGOL; NANOPARTICLE; PECTIN; TRITERPENE; URSOLIC ACID;

ANALOGS AND DERIVATIVES; ANIMAL; BAGG ALBINO MOUSE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; DRUG RELEASE; FEMALE; HALF LIFE TIME; HEMOLYSIS; HUMAN; METABOLISM; MOUSE; NEOPLASM; PARTICLE SIZE; PATHOLOGY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; CELL LINE, TUMOR; CELL SURVIVAL; DRUG CARRIERS; DRUG LIBERATION; FEMALE; HALF-LIFE; HEMOLYSIS; HUMANS; MICE; MICE, INBRED BALB C; NANOPARTICLES; NEOPLASMS; PARTICLE SIZE; PECTINS; POLYETHYLENE GLYCOLS; TRANSPLANTATION, HETEROLOGOUS; TRITERPENES;

EID: 85041470122     PISSN: 09284931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msec.2017.12.018     Document Type: Article

References (54)

1. Jones, S.B., Cancer in the developing world: a call to action. BMJ (Clinical research ed.) 319 (1999), 505–508.
2. Lópezlázaro, M., Cancer arises from stem cells: opportunities for anticancer drug discovery. Drug Discov. Today 20 (2015), 1285–1287.
3. Vaupel, P., Kallinowski, F., Okunieff, P., Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 49 (1989), 6449–6465.
4. Ritchie, J.W.A., Williams, R.J., Cancer Research, U.K., Centre for Drug Development: translating 21st-century science into the cancer medicines of tomorrow. Drug Discov. Today 20 (2015), 995–1003.
5. Donald, E., Williamson, M.D., Alabama Cancer Facts and Figures, American Cancer Society, Alabama, USA. 2003, 2003 http://adph.org/ascr/assets/AlaCancerFactsFigures2003.pdf.
6. Husband, J.E.S., Reznek, R.H., Imaging in oncology. J. Cancer Res. Ther., 93, 2004, 667.
7. WHO, World's Health Ministers Renew Commitment to Cancer Prevention and Control. http://www.who.int/cancer/media/news/cancer-prevention-resolution/en/, 2017.
8. Barreto, J.A., O'Malley, W., Kubeil, M., Graham, B., Stephan, H., Spiccia, L., Nanomaterials: applications in cancer imaging and therapy. Adv. Mater. 23 (2011), 18–40.
9. Song, C.W., Griffin, R., Park, H.J., Influence of tumor PH on therapeutic response. Cancer Drug Discov. Dev. 1 (2006), 21–42.
10. Minchinton, A.I., Tannock, I.F., Drug penetration in solid tumours. Nat. Rev. Cancer 6 (2006), 583–592.
11. Iyer, A.K., Khaled, G., Fang, J., Maeda, H., Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov. Today 11 (2006), 812–818.
12. Baban, D.F., Seymour, L.W., Control of tumour vascular permeability. Adv. Drug Deliv. Rev. 34 (1998), 109–119.
13. Maeda, H., The enhanced permeability and retention (epr) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. in Enzyme Regu. 41 (2001), 189–207.
14. Maeda, H., Wu, J., Sawa, T., Matsumura, Y., Hori, K., Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 65 (2000), 271–284.
15. Greish, K., Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. J. Drug Target. 15 (2007), 457–464.
16. Maeda, H., Matsumura, Y., Tumoritropic and lymphotropic principles of macromolecular drugs. Crit. Rev. Ther. Drug 6 (1989), 193–210.
17. Noreen, A., Nazli, Z.I., Akram, J., Rasul, I., Mansha, A., Yaqoob, N., Iqbal, R., Tabasum, S., Zuber, M., Zia, K.M., Pectins functionalized biomaterials: a new viable approach for biomedical applications: a review. Int. J. Biol. Macromol. 101 (2017), 254–272.
18. Alba, K., Kontogiorgos, V., Pectin at the oil-water interface: relationship of molecular composition and structure to functionality. Food Hydrocoll. 68 (2017), 211–218.
19. Dheer, D., Arora, D., Jaglan, S., Rawal, R.K., Shankar, R., Polysaccharides based nanomaterials for targeted anti-cancer drug delivery. J. Drug Target. 25 (2016), 1–16.
20. Glinsky, V.V., Raz, A., Modified citrus pectin anti-metastatic properties: one bullet, multiple targets. Carbohydr. Res. 344 (2009), 1788–1791.
21. Ingrassia, L., Camby, I., Lefranc, F., Mathieu, V., Nshimyumukiza, P., Darro, F., Kiss, R., Anti-galectin compounds as potential anti-cancer drugs. Curr. Med. Chem. 13 (2006), 3513–3527.
22. Ito, K., Stannard, K., Gabutero, E., Clark, A.M., Neo, S.Y., Onturk, S., Blanchard, H., Ralph, S.J., Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment. Cancer Metastasis Rev. 31 (2012), 763–778.
23. Munarin, F., Tanzi, M.C., Petrini, P., Advances in biomedical applications of pectin gels. Int. J. Biol. Macromol. 51 (2012), 681–689.
24. Naqash, F., Masoodi, F.A., Rather, S.A., Wani, S.M., Gani, A., Emerging concepts in the nutraceutical and functional properties of pectin-a review. Carbohydr. Polym. 168 (2017), 227–239.
25. Kosaraju, S.L., Colon targeted delivery systems: review of polysaccharides for encapsulation and delivery, Crit. Rev. Food Sci. 45 (2005), 251–258.
26. Neufeld, L., Bianco-Peled, H., Pectin-chitosan physical hydrogels as potential drug delivery vehicles. Int. J. Biol. Macromol. 101 (2017), 852–861.
27. Wong, T.W., Colombo, G., Sonvico, F., Pectin matrix as oral drug delivery vehicle for colon cancer treatment. AAPS PharmSciTech 12 (2011), 201–214.
28. Zong, A., Cao, H., Wang, F., Anticancer polysaccharides from natural resources: a review of recent research. Carbohydr. Polym. 90 (2012), 1395–1410.
29. Lutz, R., Aserin, A., Wicker, L., Garti, N., Structure and physical properties of pectins with block-wise distribution of carboxylic acid groups. Food Hydrocoll. 23 (2009), 786–794.
30. Zhang, W., Xu, P., Zhang, H., Pectin in cancer therapy: a review. Trends Food Sci. Technol. 44 (2015), 258–271.
31. Dutta, R.K., Sahu, S., Development of oxaliplatin encapsulated in magnetic nanocarriers of pectin as a potential targeted drug delivery for cancer therapy. Results Pharma Sci. 2 (2012), 38–45.
32. Perera, G., Barthelmes, J., Bernkop-Schnürch, A., Novel pectin-4-aminothiophenole conjugate microparticles for colon-specific drug delivery. J. Control. Release 145 (2010), 240–246.
33. Xi, M.M., Zhang, S.Q., Wang, X.Y., Fang, K.Q., Gu, Y., Study on the characteristics of pectin-ketoprofen for colon targeting in rats. Int. J. Pharm. 298 (2005), 91–97.
34. Majzoob, S., Atyabi, F., Dorkoosh, F., Kafedjiiski, K., Loretz, B., Bernkopschnürch, A., Pectin-cysteine conjugate: synthesis and in-vitro evaluation of its potential for drug delivery. J. Pharm. Pharmacol. 58 (2006), 1601–1610.
35. Tang, X.H., Xie, P., Ding, Y., Chu, L.Y., Hou, J.P., Yang, J.L., Song, X., Xie, Y.M., Synthesis, characterization, and in vitro and in vivo evaluation of a novel pectin-adriamycin conjugate. Bioorg. Med. Chem. 18 (2010), 1599–1609.
36. Hu, K., Huang, X., Gao, Y., Huang, X., Hang, X., Mcclements, D.J., Core–shell biopolymer nanoparticle delivery systems: synthesis and characterization of curcumin fortified zein-pectin nanoparticles. Food Chem. 182 (2015), 275–281.
37. Sunderland, C.J., Steiert, M., Talmadge, J.E., Derfus, A.M., Barry, S.E., Targeted nanoparticles for detecting and treating cancer. Drug Dev. Res. 67 (2006), 70–93.
38. Wang, X., Wang, Y., Chen, Z.G., Shin, D.M., Advances of cancer therapy by nanotechnology. Cancer Res. Treat. 41 (2009), 1–11.
39. Dai, L., Cao, X., Liu, K.F., Li, C.X., Zhang, G., Deng, L.H., Si, C.L., He, J., Lei, J.D., Self-assembled targeted folate-conjugated eight-arm-polyethylene glycol-betulinic acid nanoparticles for co-delivery of anticancer drugs. J. Mater. Chem. B 3 (2015), 3754–3766.
40. Nguyen, J., Steele, T.W., Merkel, O., Reul, R., Kissel, T., Fast degrading polyesters as sirna nano-carriers for pulmonary gene therapy. J. Control. Release 132 (2008), 243–251.
41. Reul, R., Nguyen, J., Kissel, T., Amine-modified hyperbranched polyesters as non-toxic, biodegradable gene delivery systems. Biomaterials 30 (2009), 5815–5824.
42. Liu, K.F., Dai, L., Li, C.X., Liu, J., Wang, L.Y., Lei, J.D., Self-assembled targeted nanoparticles based on transferrin-modified eight-arm-polyethylene glycol-dihydroartemisinin conjugate. Sci. Rep., 6, 2016, 29461.
43. Rosner, M., Schipany, K., Hengstschläger, M., Merging high-quality biochemical fractionation with a refined flow cytometry approach to monitor nucleocytoplasmic protein expression throughout the unperturbed mammalian cell cycle. Nat. Protoc. 8 (2013), 602–626.
44. Haberichter, T., Mädge, B., Christopher, R.A., Yoshioka, N., Dhiman, A., Miller, R., Gendelman, R., Aksenov, S.V., Khalil, I.G., Dowdy, S.F., A systems biology dynamical model of mammalian G1 cell cycle progression. Mol. Syst. Biol. 3:84 (2007), 1–8.
45. Unger, F., Wittmar, M., Kissel, T., Branched polyesters based on poly[vinyl-3-(dialkylamino)alkylcarbamate-co-vinyl acetate-co-vinyl alcohol]-graft-poly(, l-lactide-co-glycolide): effects of polymer structure on cytotoxicity. Biomaterials 28 (2007), 1610–1619.
46. Bawarski, W.E., Chidlowsky, E., Bharali, D.J., Mousa, S.A., Emerging nanopharmaceuticals. Nanomed. Nanotechnol. 4 (2008), 273–282.
47. Neuberger, T., Schöpf, B., Hofmann, H., Hofmann, M., Rechenberg, B.V., Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J. Magn. Mater. 293 (2005), 483–496.
48. Davis, M.E., Zhuo, C., Dong, M.S., Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7 (2008), 771–782.
49. Gullotti, E., Yeo, Y., Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery. Mol. Pharm. 6 (2008), 1041–1051.
50. Alexis, F., Pridgen, E., Molnar, L.K., Farokhzad, O.C., Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5 (2008), 505–515.
51. Wu, W., Li, R., Bian, X., Zhu, Z., Ding, D., Li, X., Jia, Z., Jiang, X., Hu, Y., Covalently combining carbon nanotubes with anticancer agent: preparation and antitumor activity. ACS Nano 3 (2009), 2740–2750.
52. Zhang, Y., Ali, S.F., Dervishi, E., Xu, Y., Li, Z., Casciano, D., Biris, A.S., Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived pc12 cells. ACS Nano 4 (2010), 3181–3186.
53. Tai, W., Mo, R., Lu, Y., Jiang, T., Gu, Z., Folding graft copolymer with pendant drug segments for co-delivery of anticancer drugs. Biomaterials 35 (2014), 7194–7203.
54. Liu, Y., Zhang, D., Qiao, Z.Y., Qi, G.B., Liang, X.J., Chen, X.G., Wang, H., A peptide-network weaved nanoplatform with tumor microenvironment responsiveness and deep tissue penetration capability for cancer therapy. Adv. Mater. 27 (2015), 5034–5042.